Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
THE most recent earnings reports across the generic drug industry have read like dispatches from the front lines of a price war.
This month, the world's largest copycat drugmaker, Israel's Teva Pharmaceutical Industries Ltd, slashed its dividend; US giant Mylan NV lowered...